SAN FRANCISCO–(COMMERCIAL WIRE)–Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-stage health technology company focused on bioelectronic medicine, today announced that it has entered into an agreement with Buffalo-based Microart Services Inc. New York, to manufacture, on a non-exclusive basis, certain components and sub-assemblies of the company’s current and future products.
“We expect that our new partnership with Microart will significantly reduce the costs of manufacturing and shipping our products,” said Ryan Sabia, Tivic Health’s chief operating officer. “We are pleased to secure highly advantageous pricing and increase scalability while maintaining the advantages of North American-based manufacturing.”
About Tivic
Tivic Health Systems, Inc. is a commercial-stage health technology company that offers non-invasive bioelectronic therapies that provide consumers with a choice in treating inflammation and other related conditions. For more information, visit https://tivichealth.com @TivicHealth.
Forward-looking statements
This press release may contain “forward-looking statements” that are subject to material risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release can be identified by the use of words such as “anticipate”, “believe”, “contemplate”, “may”, “estimate”, “expect”, “intend”, “seek”. ” “may”, “could”, “plan”, “potential”, “predict”, “project”, “target”, “target”, “should”, “will”, “would”, or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. In addition, certain forward-looking statements are based on assumptions about future events that may not be accurate. Actual results may differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: market and other conditions; the risks that the ongoing COVID-19 pandemic may disrupt Tivic’s business more severely than it has been to date or more severely than anticipated; and unexpected costs, charges or expenses that reduce Tivic’s capital resources. Given these risks and uncertainties, you are cautioned not to place undue reliance on any such forward-looking statements. For a discussion of other risks and uncertainties, and other important factors, any of which could cause Tivic’s actual results to differ from those contained in any forward-looking statements, see Tivic’s filings with the SEC, including its Annual Report in the Form 10-K for the year ended December 31, 2021, filed with the SEC on March 31, 2022, under the heading “Risk Factors,” as well as the company’s subsequent filings with the SEC. The forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no obligation to update such information, except as required by applicable law.